首页> 外文OA文献 >Antimalarial activity of ruthenium(ii) and osmium(ii) arene complexes with mono- and bidentate chloroquine analogue ligands.
【2h】

Antimalarial activity of ruthenium(ii) and osmium(ii) arene complexes with mono- and bidentate chloroquine analogue ligands.

机译:钌(ii)和锇(ii)芳烃配合物与单 - 和二齿氯喹类似物配体的抗疟活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Eight new ruthenium and five new osmium p-cymene half-sandwich complexes have been synthesized, characterized and evaluated for antimalarial activity. All complexes contain ligands that are based on a 4-chloroquinoline framework related to the antimalarial drug chloroquine. Ligands are salicylaldimine derivatives, where = N-(2-((2-hydroxyphenyl)methylimino)ethyl)-7-chloroquinolin-4-amine, and contain non-hydrogen substituents in the 3-position of the salicylaldimine ring, viz. F, Cl, Br, I, NO2, OMe and (t)Bu for , respectively. Ligand is also a salicylaldimine-containing ligand with substitutions in both 3- and 5-positions of the salicylaldimine moiety, i.e. N-(2-((2-hydroxy-3,5-di-tert-butylphenyl)methyl-imino)ethyl)-7-chloroquinolin-4-amine, while is N-(2-((1-methyl-1H-imidazol-2-yl)methylamino)ethyl)-7-chloroquinolin-4-amine) The half sandwich metal complexes that have been investigated are [Ru(η(6)-cym)()Cl] (Ru--Ru-, cym = p-cymene), [Os(η(6)-cym)()Cl] (Os--Os-, Os-, and Os-), [M(η(6)-cym)()Cl2] (M = Ru, Ru-; M = Os, Os-) and [M(η(6)-cym)()Cl]Cl (M = Ru, Ru-; M = Os, Os-). In complexes Ru--Ru- and Ru-, Os--Os-, Os- and Os- and Os-, the ligands were found to coordinate as bidentate N,O- and N,N-chelates, while in complexes Ru- and Os-, monodentate coordination of the ligands through the quinoline nitrogen was established. The antimalarial activity of the new ligands and complexes was evaluated against chloroquine sensitive (NF54 and D10) and chloroquine resistant (Dd2) Plasmodium falciparum malaria parasite strains. Coordination of ruthenium and osmium arene moieties to the ligands resulted in lower antiplasmodial activities relative to the free ligands, but the resistance index is better for the ruthenium complexes compared to chloroquine. Overall, osmium complexes appeared to be less active than the corresponding ruthenium complexes.
机译:合成了八种新的钌和五种新的对-异丙基half半三明治复合物,表征并评估了其抗疟活性。所有复合物均包含基于与抗疟疾药物氯喹有关的4-氯喹啉骨架的配体。配体是水杨醛亚胺衍生物,其中= N-(2-(((2-羟基苯基)甲基亚氨基)乙基)-7-氯喹啉-4-胺,并且在水杨醛亚胺环的3位含有非氢取代基,即。分别为F,Cl,Br,I,NO2,OMe和(t)Bu。配体还是含水杨醛亚胺的配体,在水杨醛亚胺部分的3-位和5-位均被取代,即N-(2-((2-羟基-3,5-二叔丁基苯基)甲基-亚氨基)乙基)-7-氯喹啉-4-胺,而N-(2-((1-甲基-1H-咪唑-2-基)甲基氨基)乙基)-7-氯喹啉-4-胺是已研究的是[Ru(η(6)-cym)()Cl](Ru--Ru-,cym = p-cymene),[Os(η(6)-cym)()Cl](Os-- Os-,Os-和Os-),[M(η(6)-cym)()Cl2](M = Ru,Ru-; M = Os,Os-)和[M(η(6)-cym )()Cl] Cl(M = Ru,Ru-; M = Os,Os-)。在配合物Ru-Ru-和Ru-,Os-Os-,Os-和Os-和Os-中,发现配体以二齿N,O-和N,N-螯合物配位,而在配合物Ru-并且通过s氮,建立了Os-配体的单齿配位。评估了新配体和复合物的抗疟活性,使其对氯喹敏感(NF54和D10)和对氯喹具有抵抗力(Dd2)的恶性疟原虫疟原虫菌株具有抗疟活性。钌和芳烃部分与配体的配位导致相对于游离配体较低的抗血浆活性,但是与氯喹相比,钌配合物的抗性指数更好。总体而言,络合物的活性似乎不如相应的钌络合物。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号